Hikma Pharmaceuticals PLC/ GB00B0LCW083 /
2024-08-30 11:38:35 AM | Chg. +21.00 | Volume | Bid2024-08-30 | Ask11:41:04 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2,012.00GBX | +1.05% | 2,423 Turnover(GBP): 48,750.7400 |
2,010.00Bid Size: 153 | 2,014.00Ask Size: 156 | 4.46 bill.GBP | - | - |
GlobeNewswire
2021-02-25
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
GlobeNewswire
2021-01-26
Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insu...
GlobeNewswire
2020-01-09
Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Usi...
GlobeNewswire
2019-06-03
Gout Therapeutic Market is projected to reach US$ 3820 Million by 2027- TMR